Answers are grounded in this paper and cite their sources.
Background: Malignant ascites is a common complication of epithelial ovarian cancer (EOC), leading to a considerable decline in patients' quality of life. The objective of this study is to elucidate the source of IL-10 in ascites from advanced EOC patients and investigate the possible underlying mechanisms.Methods: We collected malignant ascites from 21 patients with EOC and determined the IL-10 level by ELISA assay. In vivo studies were performed to assess the potential therapeutic effects of IL-10 antibodies. By flow cytometry and immunomagnetic beads sorting we characterized the regulatory T cells (Tregs) and M2-macrophages in EOC ascites.Finding s: IL-10 level in ascites of advanced EOC patients varied among individuals (134·38±84·80 mmol/L) and displayed a positive correlation with ascites volume (r=0·539, p=0·038) and serum CA125 level (r=0·553, p=0·014). IL-10 in ascites induced EOC cells’ migration and invasion capacity via the phosphorylation of STAT3 and ERK1/2 pathways, both in vitro and in vivo. The percentage of Tregs (3·95±2·07)% and M2-macrophage (12·57±7·78)% in EOC ascites were quantified. Furthermore, Tregs and M2-macrophages, by secreting IL-10, could promote the migration and invasion of EOC cells via the phosphorylation of STAT3 and ERK1/2 pathways.Interpretation : Our findings demonstrate that IL-10 in ascites plays a crucial role in the migration and invasion of EOC cells via the phosphorylation of STAT3 and ERK1/2 pathways. Notably, M2-macrophages and Tregs are two essential sources of IL-10 in EOC ascites.Funding:This study was supported by grants from West China Second University Hospital, Sichuan University (K1518).
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: